Impact of COVID-19 on pharma formulation: Bhupendra Pratap Singh Chauhan, CQA Head, Morepen…
Bhupendra Pratap Singh Chauhan, CQA Head, Morepen Laboratories, started his address by sharing some facts and figures with the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Morepen Laboratories
Morepen Labs Q3 revenue up by 29 per cent with 14 per cent jump in Profit Before Tax
The company also witnessed 43 per cent increase in API Export
RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India
The first batch will be shipped to the Gamaleya Center for the quality control
Morepen Group gets $100 million investment from Corinth Group
Morepen to expand its diagnostic devices business in a big way
Bulk drug manufacturers seek support from govt, regulatory authorities
Suggest fast track regulatory clearance/approval, loan term extension etc.
Morepen Labs clocks double-digit growth in its sales and net profit in FY 2019-20
Consolidated Profit before Tax (PBT) recorded extraordinary growth by 34 per cent at Rs. 39.11 crore, up from Rs. 29.18 crore in…
‘R&D continues to be the key driver for sustained growth’—Kushal Suri, Head International…
More than three decades old, research-oriented API manufacturing pharmaceutical company Morepen Laboratories has established its…
Morepen Laboratories reports net sales revenue of Rs 196.60 crore in Q2’FY 2019-20
The company's pharma division commenced commercial sales of its probiotics in India during Q1 FY 2019-20 and has made steady…
Morepen Labs adds three new drugs to its API Portfolio
The three bulk drugs/APIs are Rivaroxaban, Vildagliptin and UDCA will augment Morepen’s presence in the cardiac and diabetic…
API barcoding Benefits and bottelenecks
Recently, the Union Health Ministry announced that the government will make it mandatory for all API packages to be barcoded and…